DORTMUND, GERMANY -- (MARKET WIRE) -- May 22, 2007 -- Chimera Biotec GmbH invites scientists in the life sciences to participate in the 2007 Application Contest for ultra sensitive Imperacer™ immunoassays as advancement for ELISA. The first prize is a free feasibility study for the submitted application on Chimera Biotec’s Immuno-PCR platform Imperacer™.
